Matsumura I - Search Results

1

Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study.

Takahashi N, Tauchi T, Kitamura K, Miyamura K, Saburi Y, Hatta Y, Miyata Y, Kobayashi S, Usuki K, Matsumura I, Minami Y, Usui N, Fukuda T, Takada S, Ishikawa M, Fujimaki K, Gomyo H, Sasaki O, Ohishi K, Miyake T, Imai K, Suzushima H, Mitsui H, Togitani K, Kiguchi T, Atsuta Y, Ohtake S, Ohnishi K, Kobayashi Y, Kiyoi H, Miyazaki Y, Naoe T; Japan Adult Leukemia Study Group. Takahashi N, et al. Among authors: matsumura i. Int J Hematol. 2018 Feb;107(2):185-193. doi: 10.1007/s12185-017-2334-x. Epub 2017 Sep 19. Int J Hematol. 2018. PMID: 28929332 Clinical Trial.

2

Constitutive activation of c-kit by the juxtamembrane but not the catalytic domain mutations is inhibited selectively by tyrosine kinase inhibitors STI571 and AG1296.

Ueda S, Ikeda H, Mizuki M, Ishiko J, Matsumura I, Tanaka H, Shibayama H, Sugahara H, Takai E, Zhang X, Machii T, Kanakura Y. Ueda S, et al. Among authors: matsumura i. Int J Hematol. 2002 Dec;76(5):427-35. doi: 10.1007/BF02982808. Int J Hematol. 2002. PMID: 12512837

3

Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes.

Suzuki T, Tomonaga M, Miyazaki Y, Nakao S, Ohyashiki K, Matsumura I, Kohgo Y, Niitsu Y, Kojima S, Ozawa K. Suzuki T, et al. Among authors: matsumura i. Int J Hematol. 2008 Jul;88(1):30-35. doi: 10.1007/s12185-008-0119-y. Epub 2008 Jun 27. Int J Hematol. 2008. PMID: 18581199 Free PMC article. Review.

4

Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.

Saglio G, Kim DW, Issaragrisil S, le Coutre P, Etienne G, Lobo C, Pasquini R, Clark RE, Hochhaus A, Hughes TP, Gallagher N, Hoenekopp A, Dong M, Haque A, Larson RA, Kantarjian HM; ENESTnd Investigators. Saglio G, et al. N Engl J Med. 2010 Jun 17;362(24):2251-9. doi: 10.1056/NEJMoa0912614. Epub 2010 Jun 5. N Engl J Med. 2010. PMID: 20525993 Free article. Clinical Trial.

5

[Therapeutic choice for the chronic myeloid leukemia patients in chronic phase showing late suboptimal response to imatinib].

Matsumura I, Nannya Y, Nagai T, Tanimoto K, Fujikawa K, Kasai M, Inaguma Y, Takeuchi M, Niimi H, Kashiwagi H, Imamura Y, Yagi T, Sakamoto E, Okabe M, Aoki G, Katayama T, Okada M, Adachi Y, Saburi Y, Kizaki M. Matsumura I, et al. Rinsho Ketsueki. 2010 Dec;51(12):1762-8. Rinsho Ketsueki. 2010. PMID: 21258186 Japanese.

6

Predictability of the response to tyrosine kinase inhibitors via in vitro analysis of Bcr-Abl phosphorylation.

Shibata M, Ezoe S, Oritani K, Matsui K, Tokunaga M, Fujita N, Saito Y, Takahashi T, Hino M, Matsumura I, Kanakura Y. Shibata M, et al. Among authors: matsumura i. Leuk Res. 2011 Sep;35(9):1205-11. doi: 10.1016/j.leukres.2011.01.012. Epub 2011 Mar 26. Leuk Res. 2011. PMID: 21440936

7

Increased natural killer cells and decreased CD3(+)CD8(+)CD62L(+) T cells in CML patients who sustained complete molecular remission after discontinuation of imatinib.

Ohyashiki K, Katagiri S, Tauchi T, Ohyashiki JH, Maeda Y, Matsumura I, Kyo T. Ohyashiki K, et al. Among authors: matsumura i. Br J Haematol. 2012 Apr;157(2):254-6. doi: 10.1111/j.1365-2141.2011.08939.x. Epub 2011 Nov 11. Br J Haematol. 2012. PMID: 22077498 Free article. No abstract available.

8

[Pathogenesis and pathophysiology of chronic myeloid leukemia in chronic phase].

Hirase C, Matsumura I. Hirase C, et al. Among authors: matsumura i. Nihon Rinsho. 2012 Apr;70 Suppl 2:293-7. Nihon Rinsho. 2012. PMID: 23133970 Japanese. No abstract available.

9

[Treatment for de novo chronic myeloid leukemia in chronic phase].

Hirase C, Matsumura I. Hirase C, et al. Among authors: matsumura i. Nihon Rinsho. 2012 Apr;70 Suppl 2:298-303. Nihon Rinsho. 2012. PMID: 23133971 Japanese. No abstract available.

10

Successful anticoagulant therapy for two pregnant PNH patients, and prospects for the eculizumab era.

Morita Y, Nishimura J, Shimada T, Tanaka H, Serizawa K, Taniguchi Y, Tsuritani M, Kanakura Y, Matsumura I. Morita Y, et al. Among authors: matsumura i. Int J Hematol. 2013 Apr;97(4):491-7. doi: 10.1007/s12185-013-1302-3. Epub 2013 Mar 2. Int J Hematol. 2013. PMID: 23456264 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters